AIT Logo

Click here for details of the upcoming AIT webinars and conferences

Past Conferences and Events

  • Autumn 2021 - Virtual Webinar Series 6th October to 18th November 2021

    • Webinar 1: Specific Inhalation Pathology related to Electronic Nicotine Delivery System Devices (ENDS) presented by Elizabeth Neyens.​

    • Webinar 2: Toxicological assessment of inhalation medical devices presented by Chris Collins.

    • Webinar 3: Dose Practicum: From In Vitro to FIH, Mysteries and Secrets presented by Jeff Tepper.

    • Webinar 4: The lung effects following COVID-19 and how “good” the animal models of disease are presented by David Jones.

    • Webinar 5: Development of Rat Models of Acute Respiratory Distress Syndrome (ARDS) for Efficacy and Safety Assessment presented by Mary McElroy.

    • Webinar 6: A Mighty Approach to Generating Aerosolized Cannabidiol presented by James Randazzo.

    • Webinar 7: A combined in vitro-in silico approach for the toxicokinetic prediction of inhaled pesticides presented by Zachary Enlo-Scott.

    • Webinar 8: Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals — The Outcome of a Cross-Industry Working Group Survey presented by Jo Kilgour and Alison Wolfreys.

    • Webinar 9: Challenges of Inhaled Biologics – Pathology, Immunogenicity and Mechanisms of Toxicity presented by Peter Hall.

    • Webinar 10: Aerosol Collection and Characterization of Genetic Materials: Including a Case Study in a SARS Aerosol Transmission Model presented by Jake McDonald.

    • Webinar 11: Primate Animal Welfare / Exposure System Design presented by Simon Moore.

    • Webinar 12: Bronchial lavage (BAL) in different species (specifically primates and dogs) presented by Helen Palmer.

  • Autumn 2020 - Virtual webinar series 13th October to 22nd October 2020

    • Webinar 1:​ Inhalation Delivery and SARS Preclinical Models presented by Jake McDonald.

    • Webinar 2: Early De-risking Approaches for Identification of Anti-Fibrotics for Idiopathic Pulmonary Fibrosis (IPF) Treatment presented by Clive Roper, Mary McElroy and Jamil Aarbiou.

    • Webinar 3: Phase I: The transition from nonclinical to clinical and beyond presented by Catherine Laing.

    • Webinar 4: Regulatory Toxicology: Safety Margin Assessments of Inhalation Drug Products presented by David Jones and Luqi Pei.

  • Autumn 2019 - Brighton, UK - Discussions on Industrial Chemicals, E-Cigarettes, Biopharmaceuticals, In-Vitro Assessments and Alternatives.

  • Autumn 2018 - North Carolina, USA -  Similarities and Differences in Inhalation Toxicology between the Environmental, Pharmaceutical, Agrochemical and Chemical industries

  • Autumn 2017 - Copenhagen, Denmark - Looking into the Lung: Evaluating Toxicity of Inhaled Therapeutics

  • Autumn 2016 - Cambridge, UK - Joint conference with the BSTP - Emerging Issues in Inhalation Toxicology and Pathology

  • Autumn 2015 - Cambridge, UK - Looking into the Lung: Evaluating Toxicity of Inhaled Therapeutics

  • Autumn 2014 - Princeton NJ, USA - Joint Conference with ISAM - Inhaled Medications from the Bench to the Bedside: Preclinical, Clinical and Technical Considerations for “First in Human” and Beyond

  • Autumn 2013 - Hannover, Germany - Current topics in nanomaterials, Translational models for airways inflammation, In vitro techniques and Inhalation testing with complex atmospheres

  • Autumn 2012 - Edinburgh Capital Hotel, Edinburgh, UK - De-risking Development of Inhaled Products

  • Autumn 2011 – Hawkwell House Hotel, Oxford, UK – The 30th Annual Meeting of the Association of Inhalation Toxicologists (AIT)

  • Autumn 2010 – Steigenberger Hotel, Bad Homburg, Germany – "What's in the air?" Hot topics in Inhalation Toxicology.

  • Autumn 2009 – Grosvenor Hotel and Spa, Chester, UK – Lab to Lungs: First Steps in Respiratory Drug Development.

  • Autumn 2008 – Dublin, Ireland – Inhalation Technology: Back to the Future.

  • Autumn 2007 – New Brunswick, New Jersey – The Future for Inhalation Drug Delivery.

  • Autumn 2006 – Silver Jubilee Conference. Royal York Hotel, York, UK – Pharmaceutical Combination Products: Inhalation Delivery and Therapy.

  • Autumn 2005 – SAS Radisson Hotel, Basle, Switzerland – Ultrafines and Nanoparticles: Applications, Exposures and Experimental Aspects.

  • Autumn 2004 – Le Centre Sheraton Hotel Montreal, Quebec, Canada – Safety Assessment and delivery of Inhaled Biotechnology Products.

  • Autumn 2003 – Down Hall Country House Hotel, Bishop's Stortford,UK – Influences on current Inhalation Study Design and Open Forum

  • Autumn 2002 – Ulm / Biberach, Germany – Chronic Obstructive Pulmonary Disease Toxicology and Investigations using Juvenile Animal Models

  • Autumn 2001 – Carlton Highland Hotel, Edinburgh – Inhaled delivery of Biotech Products and the Use of Transgenics in Inhalation Toxicology

  • Autumn 2000 – Langholm Conference Centre, Stockholm – Dosing and Dosimetry and Open

  • Autumn 1999 – Swallow Hotel, Huntingdon – Ultrafine Particles / Open forum

  • Autumn 1998 – Old Swan Hotel, Harrogate – Toxicology of Inhaled Biotechnology Products/Nasal Toxicology/Open Forum & Competition for new Inhalation Toxicologists

  • Autumn 1997 – Royal Holloway College, London – Impact of Current Regulatory Guidelines/Open Presentations

  • Autumn 1996 – Hotel Bad Budendorf, Switzerland – Powder Aerosol Generation/ In Vitro Technique in Inhalation Dosing

  • Autumn 1995 – University of York – Chamber design and workshop Sessions

  • Autumn 1994 – Belmont House Hotel, Leicester – Particle sizing, Calibration and Characterisation and free presentations

  • Autumn 1993 – Inveresk Research International – Neurotoxicity Testing in Inhalation Toxicology and free presentations

  • Autumn 1992 – AEA Technology, Harwell – Legislation, Registration and Regulation in Inhalation Toxicology, Junior Forum

  • Autumn 1991 – CTL, ICI, Macclesfield – Computing in Inhalation Toxicology

  • Autumn 1990 – Holiday Inn, Birmingham – Respiratory physiology and measurement of lung function

  • Sept 1989 – Peveril of the Peak Hotel, Dovedale – Environmentally friendly aerosols, OECD protocols and air pollutants research

  • Spring 1989 – HRC Huntingdon – Respiratory Allegenicity Workshop

  • Autumn 1988 – Tralee Hotel, Bournemouth – Aerosol and Particulate Generation&monitoring

  • Spring 1988 – Old Swan Hotel, Harrogate – Hazard Assessment & Extrapolation of animal data to man

  • Spring 1987 – Holiday Inn, Birmingham – Design of Inhalation Facilities&use of computers in Inhalation Toxicology

  • Oct 1986 – Seven Hills Hotel, Cobham – Rodent respiratory tract pathology

  • April 1986 – Bath University – Respiratory rate monitoring, Measurement of Particles and Environmental parameters relevant to study design

  • Autumn 1985 – Essex University – Production & Measurement of particulate aerosols

  • Spring 1985 – Keele University – Biological aspects if Inhal Tox, Combustion Tox and cells at risk

  • Sept 1984 – York – Electrostatic effects, personal protection and Waste disposal

  • April 1984 – Swansea University – Cage design, Inhalation chamber design

  • Nov 1983 – Harwell – Joint meeting with BALR

  • Autumn 1983 – Univ of Canterbury – Legislation, QA, Data handling, Smoking effects and Welding Fume

  • April 1983 – University of Bradford – Chamber design, Generation monitoring

  • Spring 1983 – CTL, ICI – Sensory Irritation

  • Spring 1982 – Cambridge – Fibres

  • Spring 1981 – BIBRA – Inaugural meeting

  • September 1981 – Trinity College, Oxford – Problems related to Particulate Atmospheres

Quick Links